CARA - Cara Therapeutic - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Cara Therapeutic's activity chart (see below) currently has 95 price targets and 76 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 51.65% with an average time for these price targets to be met of 271.27 days.

Most recent stock forecast was given by from NEEDHAM on 13-Jun-2024. First documented stock forecast 28-Mar-2014.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-May-2023

2 years 3 months 29 days ago
(13-Jun-2024)

4/8 (50%)

$-21.05 (-80.81%)

215

Buy Since 19-Oct-2023

$3.6

2 years 3 months 29 days ago
(13-Jun-2024)

1/2 (50%)

$-23.76 (-86.84%)

239

Buy Since 07-Mar-2023

$10

$-8.25 (-45.21%)

$23

2 years 3 months 29 days ago
(13-Jun-2024)

3/3 (100%)

$-5.97 (-37.38%)

141

Buy Since 13-Mar-2019

$36

$17.75 (97.26%)

$432

2 years 10 months 28 days ago
(14-Nov-2023)

1/7 (14.29%)

$-3.42 (-8.68%)

8

Sell Since 16-May-2023

$126

$107.75 (590.41%)

$144

3 years 2 months 3 days ago
(09-Aug-2023)

3/4 (75%)

$17.28 (15.89%)

22

Show more analysts

Please expand the browser size to see the chart

What is CARA (Cara Therapeutic) average time for price targets to be met?

On average it took 271 days for the stock forecasts to be reached, with an average price target met ratio of 51.65%.

Which analyst most recently updated their price target on CARA (Cara Therapeutic)?

Which analyst has the most public recommendations on CARA (Cara Therapeutic)?

has 0 price targets and 0 ratings on CARA

Which analyst is the currently most bullish on CARA (Cara Therapeutic)?

Chris Howerton with the highest potential upside of $1673.75

Which analyst is the currently most reserved on CARA (Cara Therapeutic)?

Sumant Kulkarni with the lowest potential downside of -$8.25
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?